= 0.024), whereas vascular access type and duration were not significant. CCBs use was not associated with differences in AVF flow rate, however, its use may confer protection against AVF failure. Prospective studies are needed to confirm these findings and explore effects of antihypertensive classes on vascular access outcomes.
Elsayed et al. (Sun,) studied this question.